# Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation

> clinical trial · VERIFIED · 2026-07-27

Status: ACTIVE_NOT_RECRUITING · Sponsor: Boston Scientific Corporation · Condition: Persistent Atrial Fibrillation

- Company: Boston Scientific Corporation
- Sector: cardiology
- Primary source: https://clinicaltrials.gov/study/NCT06096337

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.